<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01414842</url>
  </required_header>
  <id_info>
    <org_study_id>HFR-AE-2006</org_study_id>
    <secondary_id>HFR-BFBCK0611</secondary_id>
    <nct_id>NCT01414842</nct_id>
  </id_info>
  <brief_title>HFR A-equilibrium on Cardiovascular Stability</brief_title>
  <acronym>AIMS</acronym>
  <official_title>Randomized Controlled Study on the Effect of the Hemodiafiltration Plasma Sodium Biofeedback System on Cardiovascular Stability in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera di Lecco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Pasteur Vallery Radot</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliera di Lecco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the present randomized controlled multinational trial is the comparison of a novel
      biofeedback system on sodium profiling applied to a endogenous hemodiafiltration therapy,
      with the standard (no sodium profiling) hemodiafiltration technique on the intradialytic
      overall and cardiovascular stability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Online hemodiafiltration (OL-HDF) has been recently associated with better patient survival
      in comparison with standard hemodialysis in some large observational studies (Canaud et al,
      KI, 2006; Vilar et al, CJASN , 2009) supporting the hypothesis that convection can improve
      patients outcomes. Moreover, it has been demonstrated in randomized controlled trials
      (Locatelli et al, Journal American Society of Nephrology, 2010) that OL-HDF significantly
      reduced the frequency of intradialytic hypotension. Nonetheless, the associated comorbidities
      and ageing of dialysis population require further devices able to improve treatment
      tolerance. Among these tools, the sodium profiling and biofeedback system seem to be
      promising to accomplish this task. But the correct intradialytic sodium balance is still far
      away today to be easily achieved. The use of an automated adaptive system dialysis to the
      sodium profiling has been investigated in a feasibility trial (Colì et al International
      Journal Artificial Organs, 2003). They also investigated the impact of such a device on
      treatment tolerance.

      The aim of this randomized multinational multicenter controlled trial is to evaluate the
      impact of sodium profiling applied to a endogenous hemodiafiltration technique on the
      intradialytic cardiovascular stability in comparison to standard no profiled endogenous
      hemodiafiltration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of dialysis complicated by at least one hypotension</measure>
    <time_frame>six months</time_frame>
    <description>Hypotension definition:
If predialysis systolic blood pressure greater than100 mmHg then a value during dialysis below 90 mmHg or any systolic blood pressure reduction greater than 25 mmHg in presence of symptoms or If predialysis systolic blood pressure less than 90 mmHg a reduction of at least 10% accompanied by symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure Intradialytic symptoms</measure>
    <time_frame>six months</time_frame>
    <description>Systolic, diastolic blood pressures (SBP, DBP) and heart rate (HR) measured at the beginning of each treatment and every 30 minutes till the end of dialysis; intradialytic symptoms (nausea, vomiting, hypotension, headache, cramps) and related clinical interventions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hypotension</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard constant (no profiled) sodium dialysate used during endogenous hemodiafiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Automated profiled</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automate sodium profiling in endogenous hemodiafiltration</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated sodium profiling in endogenous hemodiafiltration</intervention_name>
    <description>Automated sodium profiling during endogenous reinfusion hemodiafiltration technique. The device processes the dialysate sodium and ultrafiltration rate during dialysis to achieve a preset sodium target at the end of the treatment. Sodium dialysate and maximal ultrafiltration rate are constraint within safety limits during dialysis.</description>
    <arm_group_label>Automated profiled</arm_group_label>
    <other_name>HFR-Aequilibrium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard sodium dialysate</intervention_name>
    <description>Standard constant (no profiled) sodium dialysate used during endogenous hemodiafiltration</description>
    <arm_group_label>Standard</arm_group_label>
    <other_name>Standard HFR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with more than 30% of dialysis complicated by hypotension

          -  age between 18 and 85 yers

          -  time on dialysis greater than 6 months

          -  residual creatinine clearance less than 2 ml/min/1.73 m2

          -  native fistula or central venous catheter with blood flow rate greater than 250 ml/min

        Exclusion Criteria:

          -  Life expectancy less than 1 year

          -  solid active neoplasm

          -  pregnancy

          -  major event in the previous 3 months (ictus, myocardial infarction, cachexia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Locatelli, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Azienda Ospedaliera di Lecco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Nephrology and Dialysis Centre Pasteur Vallery Radat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Civil Hospital Bretagne Atlantique</name>
      <address>
        <city>Vannes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Internal Medicine</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nephrology and Dialysis Unit Ospedali Riuniti</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UO Nefrologia Dialisi e Trapianto Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Civil Hospital</name>
      <address>
        <city>Ciriè</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PO Lastaria</name>
      <address>
        <city>Foggia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa Sollievo della Sofferenza</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Bosco</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Val d'Hebron</name>
      <address>
        <city>Barcellona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2011</study_first_submitted>
  <study_first_submitted_qc>August 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2011</study_first_posted>
  <last_update_submitted>August 26, 2011</last_update_submitted>
  <last_update_submitted_qc>August 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera di Lecco</investigator_affiliation>
    <investigator_full_name>Francesco Locatelli</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dialysis Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

